Evidence map›Paper›PMID 33324040›Full record

ArticleDrug design, development and therapy2020

Xanthohumol Inhibits TGF-β1-Induced Cardiac Fibroblasts Activation via Mediating PTEN/Akt/mTOR Signaling Pathway.

Chuanhao Jiang, Ning Xie, Taoli Sun, Wanjun Ma, Bikui Zhang, Wenqun Li

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 112 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Microbial production of xanthohumol driven by synthetic biology approaches.World journal of microbiology & biotechnology · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Chuanhao Jiang *Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China.
Ning Xie *Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, Hunan 410013, People's Republic of China.
Taoli SunKey Laboratory Breeding Base of Hu'nan Oriented Fundamental and Applied Research of Innovative Pharmaceutics, College of Pharmacy, Changsha Medical University, Changsha, Hunan 410219, People's Republic of China.
Wanjun MaDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha 410011, People's Republic of China.
Bikui ZhangDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha 410011, People's Republic of China.
Wenqun LiDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha 410011, People's Republic of China.
Second Xiangya Hospital of Central South University · CNCentral South University · CNChangsha Medical University · CNHunan Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundXanthohumol (Xn) is the most abundant prenylated flavonoid in Hops ( MATERIALS AND

methodsThe cellTiter 96

resultsXn inhibited the TGF-β1-induced proliferation, differentiation and collagen overproduction of cardiac fibroblasts. TGF-β1 induced the down-regulated PTEN expression, Akt and mTOR phosphorylation. These effects of TGF-β1 were suppressed by Xn, while blocking of PTEN reduced Xn-mediated inhibitory effect on cardiac fibroblasts activation induced by TGF-β1.

conclusionXn inhibits TGF-β1-induced cardiac fibroblasts activation via mediating PTEN/Akt/mTOR signaling pathway.

Indexed as

AnimalsAntineoplastic AgentsCells, CulturedCell SurvivalFlavonoidsHumulusMaleMolecular StructureMyofibroblastsPropiophenonesProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseRatsRats, Sprague-DawleySignal TransductionTOR Serine-Threonine KinasesAntineoplastic AgentsFlavonoidsmTOR protein, ratPropiophenonesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePten protein, ratTgfb1 protein, ratTOR Serine-Threonine KinasesTransforming Growth Factor beta1xanthohumolcardiac fibroblastscardiac fibrosisPTEN/AKT/mTOR pathwayTGF-β1xanthohumol; Xn

Identifiers

PMID33324040
PMCPMC7732164
OpenAlexW3111591047

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.